We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stent-Assisted Angioplasty Aids Stroke Symptoms

By HospiMedica staff writers
Posted on 11 Jun 2001
A study has shown that stent-assisted angioplasty may alleviate symptoms, increase blood flow to the brain, and improve the prognosis of patients with stroke symptoms from arterial blockages in the rear of the brain. More...
The retrospective study was published in the June 2001 issue of Neurosurgery.

The study was conducted by researchers from the University of Pittsburgh (UPMC, PA, USA) and the University of Texas Southwestern Medical Center (Dallas, USA). The researchers examined the outcomes of 11 patients with stroke symptoms who underwent angioplasty and stenting of either the vertebral or basilar arteries. All of the patients had transient ischemic attacks or fixed deficits that failed to respond to medical treatment. Symptoms included headache, facial droop, loss of coordination, vertigo, and depression. After a follow-up of four months, seven of the patients no longer had recurrent symptoms, lived at home, and resumed activities at the same or better levels than before. The remaining four patients died either from complications during the procedure or several months later.

The researchers note that for surgical management of basilar or vertebral stenosis, the combined mortality and morbidity rate is 34%, while angioplasty of these arteries without stenting leads to restenosis in 20-30% of patients. Recent advances in stent technology have led to the development of a new generation of stents that allow neuroradiologists to better negotiate the arteries in the back of the neck.

"Although this study demonstrates the potential for stent-assisted angioplasty, it also demonstrates the risks associated with dilation of stenotic, often fragile, diseased vessels,” said Michael Horowitz, M.D., UPMC associate professor in the department of neurological surgery and radiology. "Long-term follow-up is needed to determine whether this treatment will improve on the natural history of the disease with medical management alone.”





Related Links:
Univ. of Pittsburgh
Univ. of Texas

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Tourniquet System
heidi– mein Tourniquet
New
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.